New coronavirus variants call for intensified surveillance, control, and vaccination efforts
New coronavirus variants call for intensified surveillance, control, and vaccination efforts – STAT
The post New coronavirus variants call for intensified surveillance, control, and vaccination efforts appeared first on Links Medicus.
Long Covid: Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge – JAMA Network Open Commentary: Lung, mobility problems plague COVID-19 patients months after recovery – UPI
The post Long Covid: Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge appeared first on Links Medicus.
4 reasons we’re seeing these worrying coronavirus variants now – Covid-19 is evolving. Why now?
4 reasons we’re seeing these worrying coronavirus variants now – Vox
The post 4 reasons we’re seeing these worrying coronavirus variants now – Covid-19 is evolving. Why now? appeared first on Links Medicus.
Covid-19: Cough, fatigue, sore throat ‘more common’ in new variant
Covid-19: Cough, fatigue, sore throat ‘more common’ in new variant – BBC Original report: Coronavirus (COVID-19) Infection Survey: characteristics of people testing positive for COVID-19 in England, 27 January 2021 – Office for National Statistics
The post Covid-19: Cough, fatigue, sore throat ‘more common’ in new variant appeared first on Links Medicus.
Editorial: Covid-19 controversies: the Tocilizumab chapter
Covid-19 controversies: the tocilizumab chapter – The BMJ Related: Contradicting earlier trials, Tocilizumab did not improve outcomes, with signs of harm, in patients with severe Covid-19 (studies and commentaries)
The post Editorial: Covid-19 controversies: the Tocilizumab chapter appeared first on Links Medicus.
Duration of culturable SARS-CoV-2 in hospitalized patients with Covid-19
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 – New England Journal of Medicine
The post Duration of culturable SARS-CoV-2 in hospitalized patients with Covid-19 appeared first on Links Medicus.
[Preprint] Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19 – medRxiv Commentary on Twitter The large colchicine RCT for covid is preprint published.It shows some consistent directional benefit for major outcomeshttps://t.co/gxtyKnMqZ5Since this is a pill, it's safe, cheap & an early intervention (as tested here, before hospital) these findings are very encouraging pic.twitter.com/uzTSkjftFp — Eric […]
The post [Preprint] Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19 appeared first on Links Medicus.
Systematic review: Cardiopulmonary resuscitation in the prone position in the operating room or in the intensive care unit
Cardiopulmonary Resuscitation in the Prone Position in the Operating Room or in the Intensive Care Unit: A Systematic Review – Anesthesia & Analgesia Commentary on Twitter (thread – click for more) ? Though the prone position is used in the OR for certain procedures and in the ICU to optimize oxygenation, prone CPR is […]
The post Systematic review: Cardiopulmonary resuscitation in the prone position in the operating room or in the intensive care unit appeared first on Links Medicus.
[Press release – not published yet] REGENERON reports positive interim data with antibody cocktail used as passive vaccine to prevent COVID-19
REGENERON REPORTS POSITIVE INTERIM DATA WITH REGEN-COV™ ANTIBODY COCKTAIL USED AS PASSIVE VACCINE TO PREVENT COVID-19 Commentaries: Regeneron’s antibody cocktail effective in preventing COVID-19 infection: study – Reuters AND Regeneron says monoclonal antibodies prevent Covid-19 in study – STAT AND Expert reaction to press release from Regeneron giving interim data from its REGEN-COV™ antibody cocktail […]
The post [Press release – not published yet] REGENERON reports positive interim data with antibody cocktail used as passive vaccine to prevent COVID-19 appeared first on Links Medicus.
[Press release – not published yet] Neutralizing antibodies bamlanivimab and etesevimab together reduced risk of COVID-19 hospitalizations and death by 70 percent
New data show treatment with Lilly’s neutralizing antibodies bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016) together reduced risk of COVID-19 hospitalizations and death by 70 percent – Lilly Commentary: Lilly antibody combo therapy cuts risk of COVID-19 deaths – Reuters Commentary on Twitter 1st Phase 3 trial results on #SARSCoV2 monoclonal antibody combination with very positive […]
The post [Press release – not published yet] Neutralizing antibodies bamlanivimab and etesevimab together reduced risk of COVID-19 hospitalizations and death by 70 percent appeared first on Links Medicus.